Treatment of comorbidities besides the treatment of primary tumor may further increase effective management of cancer

For most of the patients with cancer comorbidity had independent prognostic effect. This negative influence of comorbidity on survival of cancer might be due to several mechanisms: the increased risk of death due to the comorbid condition itself, more contra-indications for anti-cancer treatment, mo...

Full description

Saved in:
Bibliographic Details
Published in:Medical hypotheses 2006, Vol.67 (4), p.744-746
Main Authors: Aksoy, Sercan, Aksoy, Hatice, Harputluoglu, Hakan, Kilickap, Saadettin, Altundag, Kadri
Format: Article
Language:English
Subjects:
Angiogenesis Inducing Agents - adverse effects
Antineoplastic Agents - therapeutic use
Comorbidity
Disease Management
Humans
Models, Biological
Neoplasms - diagnosis
Neoplasms - drug therapy
Neoplasms - epidemiology
Neoplasms - mortality
Prognosis
Survival Rate
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:For most of the patients with cancer comorbidity had independent prognostic effect. This negative influence of comorbidity on survival of cancer might be due to several mechanisms: the increased risk of death due to the comorbid condition itself, more contra-indications for anti-cancer treatment, more indications for dose reduction and a higher rate of treatment-related complications, such as infections and cardiovascular events. It is known that in some chronic diseases (e.g., coronary artery disease, hypertension, and obesity) pro-angiogenic growth factors are increased compared to controls and mostly normalized after specific treatment. We propose that increased pro-angiogenic growth factor levels in cancer patients due to comorbidities may lead to the progression of the tumors and poor prognosis. Treatment of comorbidities besides the treatment of primary tumor may further increase effective management of cancer.
ISSN:0306-9877
1532-2777
DOI:10.1016/j.mehy.2006.04.033